Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lyra PCM"'
Autor:
Huang H, Hu C, Na J, Hart SN, Gnanaolivu RD, Abozaid M, Rao T, Tecleab YA, Pesaran T, Lyra PCM, Karam R, Yadav S, Domchek SM, de la Hoya M, Robson M, Mehine M, Bandlamudi C, Mandelker D, Monteiro ANA, Boddicker N, Chen W, Richardson ME, Couch FJ
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Dec 15. Date of Electronic Publication: 2023 Dec 15.
Autor:
Mendoza-Fandiño G; Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Corporación Universitaria Remington, Medellin, Colombia., Lyra PCM Jr; Faculdade de Ensino e Meio Ambiente, Ariquemes, RO, Brazil., Nepomuceno TC; Instituto Nacional de Câncer, Programa de Pesquisa Clínica, Rio de Janeiro, 20231-050, Brazil., Harro CM; Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Department of Cell Biology, Microbiology, and Molecular Biology, College of Arts and Sciences, University of South Florida, Tampa, FL, USA.; Cancer Biology PhD Program, University of South Florida Tampa, Tampa, FL, 33612, USA., Woods NT; Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE, 68198, USA., Li X; Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Rangel LB; Biotechnology/RENORBIO Program, Federal University of Espírito Santo, Vitória, ES, Brazil., Carvalho MA; Instituto Nacional de Câncer, Programa de Pesquisa Clínica, Rio de Janeiro, 20231-050, Brazil.; Instituto Federal do Rio de Janeiro - IFRJ, Rio de Janeiro, 20270-021, Brazil., Couch FJ; Mayo Clinic, Rochester, MN, 55905, USA., Monteiro ANA; Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. alvaro.monteiro@moffitt.org.
Publikováno v:
European journal of human genetics : EJHG [Eur J Hum Genet] 2022 Apr; Vol. 30 (4), pp. 465-473. Date of Electronic Publication: 2021 Nov 22.
Autor:
Lyra PCM Jr; Biotechnology/RENORBIO Program, Federal University of Espírito Santo, Vitória, ES, Brazil., Nepomuceno TC; Instituto Nacional de Câncer, Programa de Pesquisa Clínica, Rio de Janeiro, Brazil.; Divisão de Pesquisa Clínica, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.; Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., de Souza MLM; Biotechnology/RENORBIO Program, Federal University of Espírito Santo, Vitória, ES, Brazil., Machado GF; Biotechnology/RENORBIO Program, Federal University of Espírito Santo, Vitória, ES, Brazil., Veloso MF; Biotechnology/RENORBIO Program, Federal University of Espírito Santo, Vitória, ES, Brazil., Henriques TB; Biotechnology/RENORBIO Program, Federal University of Espírito Santo, Vitória, ES, Brazil., Dos Santos DZ; Biotechnology/RENORBIO Program, Federal University of Espírito Santo, Vitória, ES, Brazil., Ribeiro IG; Biotechnology/RENORBIO Program, Federal University of Espírito Santo, Vitória, ES, Brazil., Ribeiro RS Jr; Biotechnology/RENORBIO Program, Federal University of Espírito Santo, Vitória, ES, Brazil., Rangel LBA; Biotechnology/RENORBIO Program, Federal University of Espírito Santo, Vitória, ES, Brazil., Richardson M; Ambry Genetics, Aliso Viejo, CA, USA., Iversen ES; Department of Statistical Science, Duke University, Durham, NC, USA., Goldgar D; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA., Couch FJ; Mayo Clinic, Rochester, MN, USA., Carvalho MA; Instituto Nacional de Câncer, Programa de Pesquisa Clínica, Rio de Janeiro, Brazil.; Instituto Federal do Rio de Janeiro-IFRJ, Rio de Janeiro, Brazil., Monteiro ANA; Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. alvaro.monteiro@moffitt.org.
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2021 Feb; Vol. 23 (2), pp. 306-315. Date of Electronic Publication: 2020 Oct 22.